News|Articles|May 15, 2016
- Pharmaceutical Technology-05-15-2016
- Volume 2016 eBook
- Issue 2
Measuring and Removing Genotoxic Impurities
Author(s)Agnes Shanley
Electrophilic and other reactive compounds, and their precursors, must be measured and removed to ensure patient safety.
Advertisement
Electrophilic and other reactive compounds, and their precursors, must be measured and removed to ensure patient safety.
Download
.
Articles in this issue
about 10 years ago
Qualification and Validation of Single-Use Shipping Systemsabout 10 years ago
Revised ISO Cleanroom Standards Improve Air Cleanliness Classificationabout 10 years ago
Lessons Learned Accelerate Vaccine Developmentabout 10 years ago
Protecting the Product and the Patientabout 10 years ago
Deconstructing the Regulatory SpiralAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
European Biotechs Reshaping Respiratory Disease
2
GSK Cambridge Move Signals Shift in Drug Scale-Up Strategy
3
Midyear 2026 Industry Report: Taking Stock of Pharma Manufacturing, AI, and Regulatory Trends
4
Six Months In: A 2026 Progress Check on Pharma Manufacturing, AI, and Regulatory Shifts
5